Eugenia Rinaldi

Eugenia Rinaldi

Auto-generated profile, based on publicly available information

Eugenia Rinaldi

Berlin Institute of Health, Charité Universitätsmedizin, Berlin, Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2022 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
EREugenia Rinaldi
Eugenia Rinaldi
Caroline StellmachCaroline Stellmach
Caroline Stellmach
NRNaveen Moses Raj Rajkumar
Naveen Moses Raj Rajkumar
NCNatascia Caroccia
Natascia Caroccia
CDChiara Dellacasa
Chiara Dellacasa
STSylvia Thun
Sylvia Thun
The European project ORCHESTRA intends to create a new pan-European cohort to rapidly advance the knowledge of the effects and treatment of COVID-19. Establishing processes that facilitate the merging of heterogeneous clusters of retrospective data was an essential challenge. In addition, data from new ORCHESTRA prospective studies have to be compatible with earlier collected information to be efficiently combined. In this article, we describe how we utilized and contributed to existing standard terminologies to create consistent semantic representation of over 2500 COVID-19-related variables taken from three ORCHESTRA studies. The goal is to enable the semantic interoperability of data within the existing project studies and to create a common basis of standardized elements available for the design of new COVID-19 studies. We also identified 743 variables that were commonly used in two of the three prospective ORCHESTRA studies and can therefore be directly combined for analysis purposes. Additionally, we actively contributed to global interoperability by submitting new concept requests to the terminology Standards Development Organizations.

23 September 2023 in Scientific Data
Verified
Journal Article
Open access
PDF file
EREugenia Rinaldi
Eugenia Rinaldi
CDCora Drenkhahn
Cora Drenkhahn
BGBenjamin Gebel
Benjamin Gebel
KSKutaiba Saleh
Kutaiba Saleh
HTHauke Tönnies
Hauke Tönnies
STSylvia Thun
Sylvia Thun
The COVID-19 pandemic has made it clear: sharing and exchanging data among research institutions is crucial in order to efficiently respond to global health threats. This can be facilitated by defining health data models based on interoperability standards. In Germany, a national effort is in progress to create common data models using international healthcare IT standards. In this context, collaborative work on a data set module for microbiology is of particular importance as the WHO has declared antimicrobial resistance one of the top global public health threats that humanity is facing. In this article, we describe how we developed a common model for microbiology data in an interdisciplinary collaborative effort and how we make use of the standard HL7 FHIR and terminologies such as SNOMED CT or LOINC to ensure syntactic and semantic interoperability. The use of international healthcare standards qualifies our data model to be adopted beyond the environment where it was first developed and used at an international level.

14 August 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
AAAnna Maria Azzini
Anna Maria Azzini
LCLorenzo Maria Canziani
Lorenzo Maria Canziani
RDRuth Joanna Davis
Ruth Joanna Davis
MMMassimo Mirandola
Massimo Mirandola
MHMichael Hoelscher
Michael Hoelscher
ETEvelina Tacconelli
Evelina Tacconelli
ORCHESTRA (“Connecting European Cohorts to Increase Common and Effective Response To SARS-CoV-2 Pandemic”) is an EU-funded project which aims to help rapidly advance the knowledge related to the prevention of the SARS-CoV-2 infection and the management of COVID-19 and its long-term sequelae. Here, we describe the early results of this project, focusing on the strengths of multiple, international, historical and prospective cohort studies and highlighting those results which are of potential relevance for vaccination strategies, such as the necessity of a vaccine booster dose after a primary vaccination course in hematologic cancer patients and in solid organ transplant recipients to elicit a higher antibody titer, and the protective effect of vaccination on severe COVID-19 clinical manifestation and on the emergence of post-COVID-19 conditions. Valuable data regarding epidemiological variations, risk factors of SARS-CoV-2 infection and its sequelae, and vaccination efficacy in different subpopulations can support further defining public health vaccination policies.

27 September 2024 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
SRStephanie M. van Rooden
Stephanie M. van Rooden
SWSuzanne D. van der Werff
Suzanne D. van der Werff
MMMaaike S. M. van Mourik
Maaike S. M. van Mourik
FLFrederikke Lomholt
Frederikke Lomholt
KMKarina Lauenborg Møller
Karina Lauenborg Møller
EREugenia Rinaldi
Eugenia Rinaldi
Automation of surveillance of infectious diseases—where algorithms are applied to routine care data to replace manual decisions—likely reduces workload and improves quality of surveillance. However, various barriers limit large-scale implementation of automated surveillance (AS). Current implementation strategies for AS in surveillance networks include central implementation (i.e. collecting all data centrally, and central algorithm application for case ascertainment) or local implementation (i.e. local algorithm application and sharing surveillance results with the network coordinating center). In this perspective, we explore whether current challenges can be solved by federated AS. In federated AS, scripts for analyses are developed centrally and applied locally. We focus on the potential of federated AS in the context of healthcare associated infections (AS-HAI) and of severe acute respiratory illness (AS-SARI). AS-HAI and AS-SARI have common and specific requirements, but both would benefit from decreased local surveillance burden, alignment of AS and increased central and local oversight, and improved access to data while preserving privacy. Federated AS combines some benefits of a centrally implemented system, such as standardization and alignment of an easily scalable methodology, with some of the benefits of a locally implemented system including (near) real-time access to data and flexibility in algorithms, meeting different information needs and improving sustainability, and allowance of a broader range of clinically relevant case-definitions. From a global perspective, it can promote the development of automated surveillance where it is not currently possible and foster international collaboration.The necessary transformation of source data likely will place a significant burden on healthcare facilities. However, this may be outweighed by the potential benefits: improved comparability of surveillance results, flexibility and reuse of data for multiple purposes. Governance and stakeholder agreement to address accuracy, accountability, transparency, digital literacy, and data protection, warrants clear attention to create acceptance of the methodology. In conclusion, federated automated surveillance seems a potential solution for current barriers of large-scale implementation of AS-HAI and AS-SARI. Prerequisites for successful implementation include validation of results and evaluation requirements of network participants to govern understanding and acceptance of the methodology.

9 May 2025 in JMIR Medical Informatics
Verified
Journal Article
Open access
ESEduardo Salgado-Baez
Eduardo Salgado-Baez
RHRaphael Heidepriem
Raphael Heidepriem
Renate Delucchi DanhierRenate Delucchi Danhier
Renate Delucchi Danhier
EREugenia Rinaldi
Eugenia Rinaldi
VRVishnu Ravi
Vishnu Ravi
JSJulian Sass
Julian Sass
Background: Medication errors represent a widespread, hazardous, and costly challenge in health care settings. The lack of interoperable medication data within and across hospitals not only creates an administrative burden through redundant data entry but also increases the risk of errors due to human mistakes, imprecise data transformations, and misinterpretations. While digital solutions exist, fragmented systems and nonstandardized data hinder effective medication management. Objective: This study aimed to assess medication data available across the multiple systems of a large university hospital, identify a minimum dataset with the most relevant information, and propose a standard interoperable FHIR-based solution that can import and transfer information from a standardized drug master database to various target systems. Methods: Medication data from all relevant departments of a large German hospital were thoroughly analyzed. To ensure interoperability, data elements for developing a minimum dataset were defined based on relevant medication identifiers, the Health Level 7 Fast Health Interoperability Resources (HL7 FHIR) standard, and the German Medical Informatics Initiative (MII) specifications. To enhance medication identification accuracy, the dataset was further enriched with information from Germany’s most comprehensive drug database and European Standard Drug Terms (EDQM) to further enrich medication identification accuracy. Finally, data on 60 frequently used medications in the institution were systematically extracted from multiple medication systems used in the institution and integrated into a new structured, dedicated database. Results: The analysis of all the available medication datasets within the institution identified 7964 drugs. However, limited interoperability was observed due to a fragmented local IT infrastructure and challenges in medication data standardization. Data integrated and available in the new structured medication dataset with key elements to ensure data identification accuracy and interoperability, successfully enabled the generation of medication order messages, ensuring medication interoperability, and standardized data exchange. Conclusions: Our approach addresses the lack of interoperability in medication data and the need for standardized data exchange. We propose a minimum set of data elements aligned with German and international coding systems to be used in combination with the FHIR standard for processes such as the digital transfer of discharge medication prescriptions from intensive care units to general wards, which can help to reduce medication errors and enhance patient safety.

10 June 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
Caroline StellmachCaroline Stellmach
Caroline Stellmach
SPSina Marie Pütz
Sina Marie Pütz
TJThomas Jaenisch
Thomas Jaenisch
SMSusana Marina Nunes de Miranda
Susana Marina Nunes de Miranda
EREugenia Rinaldi
Eugenia Rinaldi
LNLEOSS The NAPKON
LEOSS The NAPKON
Background: It is necessary to harmonize and standardize data variables used in case report forms (CRFs) of clinical studies to facilitate the merging and sharing of the collected patient data across several clinical studies. This is particularly true for clinical studies that focus on infectious diseases. Public health may be highly dependent on the findings of such studies. Hence, there is an elevated urgency to generate meaningful, reliable insights, ideally based on a high sample number and quality data. The implementation of core data elements and the incorporation of interoperability standards can facilitate the creation of harmonized clinical data sets. Objective: This study’s objective was to compare, harmonize, and standardize variables focused on diagnostic tests used as part of CRFs in 6 international clinical studies of infectious diseases in order to, ultimately, then make available the panstudy common data elements (CDEs) for ongoing and future studies to foster interoperability and comparability of collected data across trials. Methods: We reviewed and compared the metadata that comprised the CRFs used for data collection in and across all 6 infectious disease studies under consideration in order to identify CDEs. We examined the availability of international semantic standard codes within the Systemized Nomenclature of Medicine - Clinical Terms, the National Cancer Institute Thesaurus, and the Logical Observation Identifiers Names and Codes system for the unambiguous representation of diagnostic testing information that makes up the CDEs. We then proposed 2 data models that incorporate semantic and syntactic standards for the identified CDEs. Results: Of 216 variables that were considered in the scope of the analysis, we identified 11 CDEs to describe diagnostic tests (in particular, serology and sequencing) for infectious diseases: viral lineage/clade; test date, type, performer, and manufacturer; target gene; quantitative and qualitative results; and specimen identifier, type, and collection date. Conclusions: The identification of CDEs for infectious diseases is the first step in facilitating the exchange and possible merging of a subset of data across clinical studies (and with that, large research projects) for possible shared analysis to increase the power of findings. The path to harmonization and standardization of clinical study data in the interest of interoperability can be paved in 2 ways. First, a map to standard terminologies ensures that each data element’s (variable’s) definition is unambiguous and that it has a single, unique interpretation across studies. Second, the exchange of these data is assisted by “wrapping” them in a standard exchange format, such as Fast Health care Interoperability Resources or the Clinical Data Interchange Standards Consortium’s Clinical Data Acquisition Standards Harmonization Model.